AlphaVac System for Treating Acute Pulmonary Embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a device that suctions blood clots from the lungs in people with a moderate-risk pulmonary embolism. The goal is to see if it is safe and effective at removing clots and improving blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms of a pulmonary embolism that started within the last 14 days and it was confirmed by a CT scan.
- Your blood pressure is 90 mmHg or higher and your heart rate is 130 beats per minute or less before the procedure.
- You have a right-to-left heart ratio of 0.9 or higher on imaging.
- You are at least 18 years old and can give consent.
- You are not pregnant, not on certain blood thinners that can't be stopped, and have no recent major surgery or trauma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the Vibrato Aspiration System, a device that suctions blood clots from the lungs in people with a recent pulmonary embolism (PE). It aims to see if the procedure is safe and works well for removing clots.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
This trial tests a procedure to remove blood clots from the lungs using a tube (catheter) to open blocked vessels. It may help people with a sudden pulmonary embolism who are stable enough to undergo the procedure.
This trial tests a device that removes blood clots from the lungs in people with a recent pulmonary embolism. It may help improve blood flow and reduce strain on the heart.
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
Hear when a new Pulmonary Embolism Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.